Thursday, January 24, 2019

Bristol-Myers Q4 Adj. Profit Beats View; Withdraws SBLA For Opdivo Plus Yervoy

Bristol-Myers Squibb Co. on Thursday reported a turnaround to profit in the fourth quarter, while the year-ago period's reflected the negative impact from the U.S. tax reform. Adjusted earnings per share beat analysts' expectations, while revenues missed estimates. Looking ahead, the company affirmed its earnings outlook for fiscal 2019.

from RTT - Earnings http://bit.ly/2RLY02b
via IFTTT

No comments:

Post a Comment